Abstract
This pilot study suggests that changes in prescribing policy for nicotine replacement patches should be made only when evidence of cost-effectiveness can be adduced from a randomized controlled trial.
Full Text
The Full Text of this article is available as a PDF (27.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fowler G. Nicotine replacement therapy should be prescribable on NHS. BMJ. 1997 Jun 21;314(7097):1827–1827. doi: 10.1136/bmj.314.7097.1827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes J. R., Wadland W. C., Fenwick J. W., Lewis J., Bickel W. K. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev Med. 1991 Jul;20(4):486–496. doi: 10.1016/0091-7435(91)90046-7. [DOI] [PubMed] [Google Scholar]